Jan. 23, 2014 – The Coalition for Healthcare Communication would like to receive feedback from its members regarding the FDA social media draft guidance released Jan. 13: “Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics.” (See related article at http://www.cohealthcom.org/?p=2439.)The Coalition is creating a subcommittee of its members to develop comments to the agency on this important draft guidance. Interested parties should contact Coalition Executive Director John Kamp via e-mail at [email protected].
